![Andrew Kim](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Andrew Kim
Keine laufenden Positionen mehr
Karriereverlauf von Andrew Kim
Ehemalige bekannte Positionen von Andrew Kim
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Neotx Holdings Ltd.
![]() Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Neotx Holdings Ltd. develops oncology drugs. The company was founded by Marcel Rozencweig, Robert Harow and Asher Nathan in 2014 and is headquartered in Rehovot, Israel. | Direktor/Vorstandsmitglied | 20.02.2020 | - |
ZyVersa Therapeutics Operating, Inc.
![]() ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Direktor/Vorstandsmitglied | - | - |
Statistik
International
Vereinigte Staaten | 2 |
Israel | 2 |
Operativ
Director/Board Member | 2 |
Sektoral
Health Technology | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
ZyVersa Therapeutics Operating, Inc.
![]() ZyVersa Therapeutics Operating, Inc. Pharmaceuticals: MajorHealth Technology ZyVersa Therapeutics Operating, Inc. operates as a specialty pharmaceutical company, which develops and commercializes prescription pharmaceutical products. The firm focuses on developing products for the treatment of men?s health, as well as for other markets where current therapies are suboptimal and underdeveloped. It offers VAR 100, an oral formulation of native testosterone to treat male hypogonadism; and VAR 200 that minimizes and prevents kidney cell damage, and improves focal segmental glomerulosclerosis prognosis. The company was founded by Stephen C. Glover and Shawn M. Titcomb in 2014 and is headquartered in Weston, FL. | Health Technology |
Neotx Holdings Ltd.
![]() Neotx Holdings Ltd. Pharmaceuticals: MajorHealth Technology Neotx Holdings Ltd. develops oncology drugs. The company was founded by Marcel Rozencweig, Robert Harow and Asher Nathan in 2014 and is headquartered in Rehovot, Israel. | Health Technology |
- Börse
- Insiders
- Andrew Kim
- Erfahrung